These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6109528)
1. Side effects in preventive maintenance therapy with neuroleptics with special emphasis on tardive dyskinesia. Logothetis J; Paraschos A; Frangos E Bibl Psychiatr; 1981; (160):22-9. PubMed ID: 6109528 [TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Marsden CD; Jenner P Psychol Med; 1980 Feb; 10(1):55-72. PubMed ID: 6104342 [TBL] [Abstract][Full Text] [Related]
4. The current status of tardive dyskinesia. Sachdev PS Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961 [TBL] [Abstract][Full Text] [Related]
6. Classification of neuroleptics: implications for tardive dyskinesia. Christensen AV Pol J Pharmacol Pharm; 1985; 37(3):295-309. PubMed ID: 2866499 [TBL] [Abstract][Full Text] [Related]
7. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. Bitton V; Melamed E J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157 [TBL] [Abstract][Full Text] [Related]
8. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group. Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362 [TBL] [Abstract][Full Text] [Related]
9. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [TBL] [Abstract][Full Text] [Related]
10. An update on tardive dyskinesia. Simpson GM; Pi EH; Sramek JJ Hosp Community Psychiatry; 1986 Apr; 37(4):362-9. PubMed ID: 2870977 [TBL] [Abstract][Full Text] [Related]
11. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study. Rondot P; Bathien N Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446 [No Abstract] [Full Text] [Related]
12. Current psychopathological theories of tardive dyskinesia and their implications for future research. Ananth J Neuropsychobiology; 1982; 8(4):210-22. PubMed ID: 6127649 [TBL] [Abstract][Full Text] [Related]
13. Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia. Ebadi M; Hama Y Neurosci Biobehav Rev; 1988; 12(3-4):179-87. PubMed ID: 2906420 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients. Hansen TE; Brown WL; Weigel RM; Casey DE J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762 [TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia: review and update. Klawans HL; Goetz CG; Perlik S Am J Psychiatry; 1980 Aug; 137(8):900-8. PubMed ID: 6106395 [TBL] [Abstract][Full Text] [Related]